Published in Cancer Causes Control on April 12, 2009
Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma. BMC Cancer (2010) 0.80
Association between body mass index and mortality in patients with glioblastoma mutliforme. Cancer Causes Control (2010) 0.78
Case-specific potentiation of glioblastoma drugs by pterostilbene. Oncotarget (2016) 0.78
Malignant gliomas in adults. N Engl J Med (2008) 20.54
Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst (2008) 5.09
Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther (2004) 1.84
History of allergies among adults with glioma and controls. Int J Cancer (2002) 1.78
Development and validation of a food frequency questionnaire for the assessment of dietary total antioxidant capacity. J Nutr (2007) 1.71
Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol (1997) 1.63
Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA) Cancer Causes Control (1997) 1.63
Antioxidant activities of flavonoids as bioactive components of food. Biochem Soc Trans (1996) 1.53
Understanding the association between dietary antioxidants, redox status and disease: is the Total Antioxidant Capacity the right tool? Redox Rep (2004) 1.48
Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res (2004) 1.27
Nonsynonymous coding single-nucleotide polymorphisms spanning the genome in relation to glioblastoma survival and age at diagnosis. Clin Cancer Res (2007) 1.23
Diet and brain cancer in adults: a case-control study in northeast China. Int J Cancer (1999) 1.11
Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trial. Nat Clin Pract Neurol (2005) 1.11
Diet and risk of adult glioma in eastern Nebraska, United States. Cancer Causes Control (2002) 1.02
Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Sci (2007) 1.01
Inhibiting catalase activity sensitizes 36B10 rat glioma cells to oxidative stress. Free Radic Biol Med (2006) 0.99
The validity and reproducibility of food-frequency questionnaire-based total antioxidant capacity estimates in Swedish women. Am J Clin Nutr (2008) 0.98
Occupation and adult gliomas in the San Francisco Bay Area. J Occup Environ Med (2003) 0.95
Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2). Free Radic Biol Med (2008) 0.94
Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival. J Neurooncol (2006) 0.92
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone. Oncology (1996) 0.91
Expression of superoxide dismutases, catalase, and glutathione peroxidase in glioma cells. Free Radic Biol Med (1999) 0.90
Dietary prevention of malignant glioma aggressiveness, implications in oxidant stress and apoptosis. Int J Cancer (2008) 0.88
Glutathione-S-transferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev (2004) 0.88
Inverse association of antioxidant and phytoestrogen nutrient intake with adult glioma in the San Francisco Bay Area: a case-control study. BMC Cancer (2006) 0.86
Role of antioxidant enzyme expression in the selective cytotoxic response of glioma cells to gamma-linolenic acid supplementation. Free Radic Biol Med (2000) 0.86
Peroxiredoxins and antioxidant enzymes in pilocytic astrocytomas. Clin Neuropathol (2007) 0.84
Study of the antioxidant enzymes in human brain tumors. J Neurooncol (1996) 0.83
Hypotheses concerning roles of dietary energy, cured meat, and serum tocopherols in adult glioma development. Neuroepidemiology (1999) 0.78
Dental x-rays and risk of meningioma. Cancer (2012) 5.99
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet (2009) 5.13
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med (2015) 5.03
Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer (2008) 3.98
Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics (2008) 3.89
Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol (2006) 3.76
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Epidemiology and etiology of meningioma. J Neurooncol (2010) 3.64
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18
The landscape of recombination in African Americans. Nature (2011) 3.06
Epidemiology of intracranial meningioma. Neurosurgery (2005) 2.60
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet (2011) 2.43
Epidemiology of brain tumors. Neurol Clin (2007) 2.38
Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan. J Clin Oncol (2008) 2.32
Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis (2005) 1.97
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
History of allergies among adults with glioma and controls. Int J Cancer (2002) 1.78
Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet (2011) 1.77
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet (2012) 1.73
Long-term outcomes in patients with treated childhood hydrocephalus. J Neurosurg (2007) 1.59
Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests. Cancer Epidemiol Biomarkers Prev (2008) 1.56
Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshop. J Neurosurg Spine (2010) 1.45
Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev (2005) 1.44
GLIOGENE an International Consortium to Understand Familial Glioma. Cancer Epidemiol Biomarkers Prev (2007) 1.42
SNPLogic: an interactive single nucleotide polymorphism selection, annotation, and prioritization system. Nucleic Acids Res (2008) 1.42
Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol (2010) 1.40
Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control (2008) 1.38
IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer (2009) 1.35
Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res (2004) 1.34
DNA quantification of whole genome amplified samples for genotyping on a multiplexed bead array platform. Cancer Epidemiol Biomarkers Prev (2007) 1.31
Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev (2007) 1.22
Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer (2007) 1.20
Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev (2009) 1.19
Inherited variation in immune genes and pathways and glioblastoma risk. Carcinogenesis (2010) 1.17
Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Neuro Oncol (2006) 1.15
DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology (2007) 1.15
Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme. Am J Epidemiol (2004) 1.15
Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies. Genet Epidemiol (2012) 1.13
Multiple sclerosis mortality and patterns of comorbidity in the United States from 1990 to 2001. Neuroepidemiology (2005) 1.12
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Neuro Oncol (2013) 1.11
HMG CoA reductase inhibitors, NSAIDs and risk of glioma. Int J Cancer (2012) 1.10
Longitudinal patterns of chemotherapy use in metastatic colorectal cancer. J Oncol Pract (2009) 1.10
Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol (2011) 1.09
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res (2011) 1.05
Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma. Cancer Res (2010) 1.00
Fine mapping of chromosome 15q25.1 lung cancer susceptibility in African-Americans. Hum Mol Genet (2010) 0.99
Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies. Int J Cancer (2011) 0.99
Positive and negative associations of human leukocyte antigen variants with the onset and prognosis of adult glioblastoma multiforme. Cancer Epidemiol Biomarkers Prev (2005) 0.99
Family and personal medical history and risk of meningioma. J Neurosurg (2011) 0.97
Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer (2011) 0.96
A descriptive study of variables associated with obtaining nipple aspirate fluid in a cohort of non-lactating women. BMC Womens Health (2006) 0.96
Occupation and adult gliomas in the San Francisco Bay Area. J Occup Environ Med (2003) 0.95
Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg (2012) 0.95
Increasing prevalence of gestational diabetes and pregnancy-related hypertension in Los Angeles County, California, 1991-2003. Prev Chronic Dis (2008) 0.94
Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. Eur J Cancer (2013) 0.94
Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems. BMC Cancer (2008) 0.93
Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: a historic prospective study. BMC Cancer (2008) 0.93
Epigenetic biomarkers of T-cells in human glioma. Epigenetics (2012) 0.92
Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus (2015) 0.91
Leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: a novel candidate SNP approach. Front Genet (2012) 0.88
Prevalence of congenital hydrocephalus in California, 1991-2000. Pediatr Neurol (2011) 0.87
Endogenous and exogenous hormone exposure and the risk of meningioma in men. J Neurosurg (2014) 0.86
Inverse association of antioxidant and phytoestrogen nutrient intake with adult glioma in the San Francisco Bay Area: a case-control study. BMC Cancer (2006) 0.86
PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia. Int J Cancer (2014) 0.85
Cigarette smoking and risk of meningioma: the effect of gender. Cancer Epidemiol Biomarkers Prev (2012) 0.84
A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma. Cancer Epidemiol Biomarkers Prev (2012) 0.83
Cigarette smoking associated with lung adenocarcinoma in situ in a large case-control study (SFBALCS). J Thorac Oncol (2012) 0.83
Treatment-related toxicity and supportive care in metastatic colorectal cancer. J Support Oncol (2010) 0.82
Retinoic acid inhibition of chromatin remodeling at the human immunodeficiency virus type 1 promoter. Uncoupling of histone acetylation and chromatin remodeling. J Biol Chem (2004) 0.82
Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophages. J Virol (2004) 0.81
Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Hum Genet (2012) 0.81
Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma. BMC Cancer (2010) 0.80
Assessment of autoantibodies to meningioma in a population-based study. Am J Epidemiol (2012) 0.80
A comparison of DNA methylation specific droplet digital PCR (ddPCR) and real time qPCR with flow cytometry in characterizing human T cells in peripheral blood. Epigenetics (2014) 0.80
Molecular epidemiology of glioblastoma. Cancer J (2003) 0.80
Evaluation of 39 cases of pediatric cutaneous head and neck melanoma. J Am Acad Dermatol (2010) 0.80
Risk factors for estrogen receptor-positive breast cancer. Arch Surg (2005) 0.80
Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk. Int J Cancer (2013) 0.80
SSBP2 variants are associated with survival in glioblastoma patients. Clin Cancer Res (2012) 0.79
The C3435T polymorphism of MDR1 and susceptibility to adult glioma. Neuroepidemiology (2005) 0.79
Evaluation of epidemiologic evidence for primary adult brain tumor risk factors using evidence-based medicine. Prog Neurol Surg (2006) 0.79
CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas. J Neuropathol Exp Neurol (2015) 0.79
Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation. Fam Cancer (2010) 0.78
Association between body mass index and mortality in patients with glioblastoma mutliforme. Cancer Causes Control (2010) 0.78